We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

LSEG:LSELondon Stock Exchange Group plc Analysis

Data as of 2026-09-07 - not real-time

£8,772.00

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

London Stock Exchange Group plc is priced at £8,772.00 and its moving averages line up in bearish order, the shorter trailing the longer. RSI sits at 50.7, which reads as neutral, and MACD momentum is bullish. Recent trading has carved out support near £8,354.00 and resistance around £9,076.00.
Multiples put this in fair territory: 31.6 times earnings against the sector's 16.5. Consensus targets land 34.6% above where the shares trade now. Revenue is growing at 6.7% on a 14.6% profit margin. The 1.79% dividend yield looks covered by current payout levels.
Risk scores 4 out of 10, which is moderate for this asset class. With 30-day volatility of 32.9%, a beta of 0.27 and a maximum drawdown of 27.1%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 4 out of 10.

Top Market Events

London Stock Exchange boosts dividend and launches new share buyback Financial NewsThe London Stock Exchange's partnership with Payward marks tokenization's move into institutional equity...1, September 2026 by EuropaWire PR Editor This entry was posted in Banks, Business, Financial, Internet & Online,...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading above the 200-day average of 8742.20
  • MACD momentum is positive

Medium Term

1–3 years
Neutral
Model confidence: 3/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • P/E of 31.6 versus sector average of 16.5
  • Trading above the 200-day average of 8742.20

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • P/E of 31.6 versus sector average of 16.5
  • Analyst targets imply +34.6% versus the current price
  • Dividend yield of 1.79%

Key Metrics & Analysis

Financial Health

Revenue Growth6.70%
Profit Margin14.64%
P/E Ratio31.6
ROE7.69%
ROA0.19%
Debt/Equity64.29
P/B Ratio2.3
Op. Cash Flow£3.9B
Free Cash Flow£1.7B
Industry P/E16.5

Technical Analysis

TrendBearish
RSI50.7
Support£8,354.00
Resistance£9,076.00
MA 20£8,717.20
MA 50£8,736.48
MA 200£8,742.20
MACDBullish
VolumeIncreasing
Fear & Greed Index94.59

Valuation

Fair Value£4,058.72
Target Price£11,804.00
Upside/Downside34.56%
GradeFair
TypeBlend
Dividend Yield1.79%

Risk Assessment

Beta0.27
Volatility32.90%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.